Headlands Technologies LLC Bluebird Bio, Inc. Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$0.85 - $1.26 $4,264 - $6,321	-5,017 Reduced 99.88%	6 $0
Q1 2024 May 07, 2024	BUY	$0.91 - $1.75 $4,570 - $8,790	5,023 New	5,023 $6,000
Q3 2023 Nov 09, 2023	SELL	$3.02 - $4.05 $18,479 - $24,781	-6,119 Reduced 97.69%	145 $0
Q2 2023 Aug 03, 2023	BUY	$2.79 - $5.03 $17,476 - $31,507	6,264 New	6,264 $20,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.